May 22, 2012

Claim Term “a” Does Not Necessarily Include Singular or Plural

In reviewing an interference decision of the Board of Patent Appeals and Interferences (Board), the U.S. Court of Appeals for the Federal Circuit held that the claim term “a” does not necessarily mean “one or more than one.”  The court held that construction of the term “a” should be informed by the context of its use in the claims and the specification to determine whether the applicant intended to refer to the singular or plural.  Eliyahou Harari et al. v. Roger Le, et al, Case No. 10-1075 (Fed. Cir., Sept. 1, 2011) (Moore, J.).

Plaintiff Harari provoked an interference against Lee in order to determine priority of invention between Harari’s patent application and Lee’s patents.  The patents are directed to programming erasable memory arrays for use in computers, in which “bit lines” are accessed in order to activate “memory cells.”  After the Board held that Harari’s claims were not supported by adequate written description, Harari appealed.

The Federal Circuit noted that the issue of whether Harari’s claims were supported by adequate written description “turned almost entirely on claim construction.”   In construing the claims, the Court noted that since Harari provoked an interference against Lee’s patent by substantially copying Lee’s claim, Harari’s claims are to be given their broadest reasonable interpretation in light of Lee’s disclosure.  To meet the written description requirement, however, Harari’s claims as properly construed in light of Lee’s disclosure still must be adequately described in the Harari specification. 

The Court found that Lee disclosed a one-to-one correspondence between the number of bit lines accessed and memory cells activated.   Thus, in Lee, the number of bit lines to be accessed equals the number of memory cells to be activated.  As the Court explained, this construction of “a” must be imposed on Harari’s claims. 

The relevant claim in Harari specified that a bit line activates a number of memory cells.  Harari urged that in this claim, the term “a” must necessarily mean “more than one” in order to achieve the one-to-one correspondence between the number of bit lines accessed and memory cells activated as disclosed in the Lee patents.  Harari argued that the term “a” in an open-ended claim automatically invokes such a construction.

The Court disagreed, noting that there is not “a hard and fast rule that ‘a’ always means one or more than one,” but that the limitation must be read “in light of the claim and specification to discern its meaning.”  The Court further explained that “[w]hen the claim language and specification indicate that ‘a’ means one and only one, it is appropriate to construe it as such even in the context of an open-ended ‘comprising’ claim” (emphasis added).

The relevant claim in Harari recited a number of control gates, a number of memory cells, and a bit line.  The rest of the claim explicitly referred to “said bit line” (i.e., in the singular), but to the “number” of control gates and memory cells in the plural.  The Court rejected Harari’s argument that the term “a” necessarily meant “more than one,” concluding that the “plain language of the claim clearly indicates that only a single bit line is used when accessing a number of cells” and that the specification was similarly limited. 

The Court thus affirmed the Board’s holding that the properly construed Harari claims did not have adequate written description in Harari’s application, and therefore are not patentable to Harari.

Practice Note:   When drafting open-ended claims, applicants should be careful when using the term “a” and consider whether a strict construction of either “one” or “more than one” is likely to be read into the term based on the context of the language of the claim and support in the specification.

© 2012 McDermott Will & Emery

About the Author

Associate

K. Nicole Clouse, Ph.D., is an associate in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Boston office.  She focuses her practice on patent preparation, prosecution and portfolio management in the life sciences industry.  Nicole also assists with the preparation of patentability, freedom to operate, validity and infringement opinions and advises litigation teams on technical scientific matters.  She has worked with a wide variety of clients, including biotechnology companies, pharmaceutical companies, universities,...

617-535-3841

About the Author

Partner

Robert H. Underwood is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Boston office.  Bob has extensive experience creating and evaluating intellectual property protection in the areas of life sciences and chemistry including antibody-based and other protein therapeutics, nucleic acid and genetic technology, small molecule therapeutics, medicinal chemistry, drug discovery and development, organic chemistry, polymers, catalysts, and drug formulation and delivery.  His practice focuses on patent portfolio development and management,...

617-535-4093

Boost: AJAX core statistics

Legal Disclaimer

You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  

Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. NLR does not accept advertising from attorneys or law firms. The National Law Review is not a law firm nor is www.NatLawReview.com  intended to be an advertisement or a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional.  NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us. 

Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials.